Immunization Update on ACIP Recommendations for Hepatitis B, Pneumococcal, and Zoster Vaccines


Course Number:  WC4314-042022 CE for this course has been extended through July 25, 2022. CE Info

Presenter information and topics:

Mark Weng, , MD MSc, Epidemiologist, CDC
Update: Recommendations of the Advisory Committee on Immunization Practices for Universal Hepatitis B Vaccination in Adults aged 19 through 59 years — United States, 2022

Miwako Kobayashi, MD, MPH, Epidemiologist, CDC
Recommendations on Use of New Pneumococcal Conjugate Vaccines for U.S. Adults

Tara C. Anderson, DVM, MPH, PhD, Epidemiologist, CDC
Use of Recombinant Zoster Vaccine (RZV, Shingrix) in Immunocompromised Adults Aged ≥19 Years and Considerations for Use

Download Slides
Section 508 and Accessibility:

Contact if you need help with accessibility.

Page last reviewed: April 18, 2022
Content source: April 18, 2022